Serum Institute Of India - CERVAVAC - Quadrivalent Human …
WEBCERVAVAC ® is indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types, included in the vaccine: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18.
Cervavac Vaccine: View Uses, Side Effects, Price and Substitutes
WEBCervavac Vaccine is a vaccine used to prevent cervical, vulvar, and vaginal cancers associate with human papillomavirus (HPV) in women. it works by initiating a mild infection to stimulate the body's immune system to produce antibodies to …
Press Release:Press Information Bureau
WEBSep 1, 2022 · The Minister said, the most promising intervention for preventing cervical cancer is vaccination against human papillomavirus (HPV). It is estimated that HPV types 16 and 18 (HPV-16 and HPV-18) together contribute to approximately 70% of all invasive cervical cancer cases worldwide.
India's First HPV Vaccine for Cervical Cancer - Medanta
WEBSep 25, 2023 · The introduction of Cervavac, India's first HPV vaccine, marks a significant milestone in the fight against cervical cancer. This ground-breaking vaccine offers a powerful tool for preventing HPV infection and reducing …
Serum Institute of India launches first made-in-India HPV vaccine …
WEBJan 25, 2023 · New Delhi, January 24 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Tuesday announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer.
SII Launches India's First Indigenously Made Cervical Cancer Vaccine ...
WEBJan 24, 2023 · CERVAVAC, India's first indigenously developed cervical cancer vaccine, has demonstrated a robust antibody response against all targeted HPV types, and in all dose and age groups.
Serum Institute Of India - News
WEBSep 1, 2022 · Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’. Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology announced India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine 'CERVAVAC'.
Immunogenicity and safety of a new quadrivalent HPV vaccine in …
WEBNov 7, 2023 · Existing vaccines pre-qualified by WHO to prevent HPV infection include bivalent vaccines (Cervarix 6 and Cecolin 7) targeting HPV types 16 and 18; a quadrivalent HPV vaccine (Gardasil 8) vaccine targeting HPV types 6, 11, 16, and 18; and a nonavalent vaccine (Gardasil-9 9) targeting HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. The high ...
Explained: As India Unveils SII's CERVAVAC, Know How ... - ABP LIVE
WEBSep 1, 2022 · Pune-based pharmaceutical firm Serum Institute of India (SII) will soon launch CERVAVAC, India’s first indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer.
India rolls out HPV vaccination - The Lancet Oncology
WEBMar 16, 2023 · In September 2022, the Serum Institute of India launched Cervavac, a quadrivalent HPV vaccine that it developed in partnership with the Indian government. It will be priced at INR 200–400 per dose, around £2–4, …